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Teaching Chinese medicine to a Western public that knows almostnothing about the philosophical principles of Chinese civilisationimplies overcoming a set of considerable intellectual, pedagogical,
and institutional difficulties. (1) In 2004, Professor Éric Marié, who at that
time held a position as research director at the Nanchang faculty of
Chinese Medicine in Jiangxi and also taught this discipline at Lausanne
University, (2) was invited to use his expertise to establish a university
degree that might help meet this challenge at France’s University of La
Rochelle. This degree, first supported by a letter written by the educa-
tional advisor at the Chinese Embassy in France to the university presi-
dent, and then approved by the board of directors, received numerous
registration applications but never saw the light of day. The registration
forms were returned to the students. No reason was ever given to ex-
plain why this course of studies was not ultimately launched. This expe-
rience of failure led Pierre-Henry de Bruyn, who initiated the project, to
ponder the resistance that traditional Chinese medicine encounters
when attempting to penetrate a university environment in certain
Western countries. The present article is the fruit of this reflection, en-
riched by the reflections that have led Évelyne Micollier to the Chinese
health system over the course of some 20 years. The work below con-
sists of tracing a typology of the ideological, epistemological, political,
economic, and educational issues that come together around Chinese
medicine in its transmission process, in order to identify some conside-
rations regarding its future. In the line of thinking of this particular do-
cument, we consider Chinese medicine as a world heritage, and not as
a purely Chinese or local phenomenon. This allows us to illustrate our
thoughts using observations made in China, as well as in East Asia and
the West.
The first issue: Avoiding a caricatured
ideological bipolarisation
The first difficulty we encounter when discussing Chinese medicine in a
university setting comes from the way discussions on this subject quickly
take on an ideological flavour. This problem has also existed in China for a
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* Pierre-Henry de Bruyn is a researcher at CEFC (UMIFRE no. 18 / CNRS-USR no. 3331 East Asia) and
chief editor of China Perspectives; Évelyne Micollier is a researcher at IRD (French Institute for Devel-
opment Research), UMI 233 (Unité Mixte Internationale – Joint International Unit), IRD-University of
Montpellier I. She studied Chinese medicine at the Guangzhou Institute of Chinese Medicine at the be-
ginning of the 1990s in the context of her PhD research on “An Aspect of Medical Plurality in PR China:
The Practices of Qigong, Therapeutic and Social Dimension,” PhD dissertation in anthropology, Univer-
sity of Provence, 1995.
1. Given that the term “Traditional Chinese Medicine” (TCM) chosen by the PRC since the 1950s as a
translation for the Chinese term zhongyi (“Chinese Medicine” – CM) is increasingly acquiring a limited
meaning that is not really a synonym for “Chinese medicine,” we prefer to use a literal translation of
the term here, even if we still use the acronym “TCM” for the sake of convenience. In regards to this
subject it is important to remember that “(Elisabeth) Hsu, Volker Scheid and Kim Taylor have explained
the difference between the traditional medicine promoted by the government, namely TCM, and Chi-
nese medicine in its larger acceptance. By presenting the plurality of medical practices, Scheid and
then Taylor take into account the developments of TCM since 1949: Chinese medicine has been trans-
formed into TCM by a planned state intervention.” (Évelyne Micollier, “Un savoir thérapeutique hybride
et mobile – Éclairage sur la recherche médicale en médecine chinoise en Chine aujourd’hui,” Revue
d’anthropologie des connaissances, vol. 5, no. 1, 2011, pp. 41-70; p. 47). This excerpt refers back to the
following studies: Elisabeth Hsu, The Transmission of Chinese Medicine, Cambridge UK, Cambridge Uni-
versity Press, 1999 ; —-, Chinese Medicine: Innovation, Convention and Controversy, Cambridge UK,
Cambridge University Press, 2001; Volker Scheid, Chinese Medicine in Contemporary China – Plurality
and Synthesis, Durham – London, Duke University Press, 2002, (p. 65); and Kim Taylor, Chinese Medi-
cine in Early Communist China, 1945 – 1963: A Medicine in Revolution, London, Routledge, 2005. It
should also be noted (p. 48) that “in official translations today, Chinese authors, like the Ministry of
Health, confuse TCM with Zhongyi.
2. In 2003, Éric Marié also presented a PhD dissertation in comparative history of medicine at the École
des Hautes Études en Sciences Sociales [Graduate School of Social Sciences]. This work was then pub-
lished under the title: Le diagnostic par les pouls en Chine et en Europe – Une histoire de la sphyg-
mologie des origines au XVIII e siècle (Diagnosis by pulse in China and in Europe – A history of sphyg-
mology from the beginning to the eighteenth century), Paris-Berlin-New York, Springer, 2011.
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number of years, as could be observed in 2006 with the mediated debate
centring around an article by Zhang Gongyao, professor of philosophy of
science at Changsha University, which considered the issue of including
TCM in the Chinese public health system. (3) Meanwhile in the West, this
ideological aspect is even more pronounced in that it also crosses the nar-
row field of several specialists in this discipline, as we shall demonstrate.
The “national character” of “Chinese” medicine involuntarily reveals these
deep reflexes in the Western world that determine people’s attitudes to-
ward the Other. In the preface of a book on the practice of acupuncture in
the West published in 1997, Giovanni Maciocia thus pointed out:
Practically ever since Oriental medicine was introduced to the
Western world, at least in recent times, there has been a dynamic
tension between the need to absorb, understand and preserve Ori-
ental medicine and the need to adapt it to Western conditions. Two
opposing views could be presented, the first advocating the need to
swiftly adapt Oriental medicine to Western conditions, the second
advocating the need to first absorb, understand and master Oriental
medicine as it has been handed down in Asia. (4)
Western discussions of Chinese medicine thus cross lines of tension be-
tween a centripetal and centrifugal motion. The centripetal motion con-
sists of trying to absorb the differences of the Other by filtering the con-
tent of his knowledge and experiences into familiar categories of thinking.
This is often found, for example, in Western faculties of medicine. In this
kind of environment, the only aspects of Chinese medicine deemed worthy
of interest are those that can join your “centre” in a fractional manner, or
expressed differently, your mode of thinking: foreign medical tradition
stops being “Chinese,” but certain aspects are considered possibly to be
worth “medical” interest because of their therapeutic effectiveness. (5) At
the opposite end of the spectrum, the centrifugal approach tries to stress
the exotic characteristics of the discipline: it is cultivated by numerous pri-
vate schools of Chinese medicine but also in university environments in
the faculties of Chinese studies, where it is brought into the medical di-
mension through its “Chinese” character: Chinese medicine thus becomes
Chinoiserie.
It is important to stress that no environment, including that of specialists
in Chinese medicine, escapes this tension. For example, we can observe
that Western historians of Chinese medicine, based on their intellectual or
ideological prejudices, often present divergent points of view in their inter-
pretations of contemporary history. Thus the anthropologist Elisabeth Hsu,
in the preface of her collective work Innovation in Chinese Medicine, intro-
duced the articles of Volker Scheid and Kim Taylor, specialists in the history
of Chinese medicine, while stressing the following contrast:
When Taylor highlights unification through political indoctrination,
Scheid emphasizes pluralism in government institutions; where Taylor
mentions application of the Soviet sciences, Scheid stresses adapta-
tion of Western medicine; and where Taylor shows how canonical
knowledge was done away with, Scheid delves into cracking medical
lineages and establishes genealogies of drug prescriptions. (6)
The contrast between positive prejudices toward Chinese medicine, such
as those of Volker Scheid, or negative, as with Kim Taylor, is moreover not
new. The parallels with two other specialists, Manfred Porkert and Paul Un-
schuld, confirm this: the former defends the profoundly scientific character
of Chinese medicine, while the latter considers the use of this discipline in
the West to be mainly a response to an ideological and spiritual void.
Manfred Porkert holds:
At present three major factors work together in the debasement of
Chinese medicine. The first, most visible and much dreaded, is the
apparent power, in appearance overwhelming and universal, of or-
thodox Western medicine. The second, widespread and much publi-
cised in all industrialised Western countries, is the acclaim and in-
terest Chinese medicine gets from practitioners of what is called
“alternative” medicine. (7) And the third, by far the most serious,
menace is the bungling and degradation Chinese medicine suffers
from some of its most prominent speakers in China proper. (8)
And yet, according to Porkert, Chinese medicine is “a science in its own
right,” the existence of which offers the medical profession a unique op-
portunity for potential development, as little as it may be recognised as
such. (9) It is in this same line of thought that certain authors today are
writing veritable comparative chronological tables, thus indirectly attribu-
ting to the history of Chinese medicine an importance comparable to that
of Western medicine. One of the most eminent examples of this type of
work is the collection inaugurated in 2004 under the very telling title of
Bridging Hippocrates and Huang Ti. (10)
In contrast to this viewpoint, Paul Unschuld considers instead the current
idolatry of “nature” in the West, which... 
…required a theology, and this was certainly not offered by the use
of water, warmth, heat, light, and air. This is too primitive. So-called
Chinese medicine was better equipped to provide the required 
theology. It simultaneously presented itself as a secularized religion.
[...] The “theology” of Chinese medicine gives answers that believers
in the churches of conventional religion have to live without. Of
course, this “theology” is not theology, because it has no Theos. The
yin-yang and five agents doctrines are the cosmology of a secular
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3. See Évelyne Micollier, “Un savoir thérapeutique hybride et mobile – Éclairage sur la recherche médicale
en médecine chinoise en Chine aujourd’hui,” Revue d’anthropologie des connaissances, vol. 5, no. 1,
2011, pp. 41-70, p. 49 ; —-, “Management of the AIDS Epidemic and Local/Global Use of Chinese Med-
icine,” in Évelyne Micollier (ed.), Chinese Society confronted with AIDS: Social Responses and Cultural
Politics, Special Feature, China Perspectives, no. 77, 2009, pp. 67-78, 72-73.
4. Giovanni Maciocia, “Foreword,” in Hugh MacPherson, Ted J. Kaptchuk (eds.), Acupuncture in Practice –
Case History Insights from the West, London, Elsevier Limited, 1997, p. ix.
5. The article by Lucia Candelise in this issue shows that in France, there was a strong reaction among
acupuncture doctors against this centripetal tendency, which created a current among them that she
called “traditionalist.” Also see Ronald Guilloux, “Évolution de la ‘tradition’ dans la réception de
l’acupuncture chinoise en France (1860-1980),” Revue d’anthropologie des connaissances, vol. 5, no. 1,
2011, pp. 13-40.
6. Elisabeth Hsu (ed.), Innovation in Chinese Medicine, Cambridge, Cambridge University Press, 2001, p. 8.
7. Chinese medicine would thus be reduced to no more than a somewhat ethereal holistic therapeutic
technique manipulated by New Age and natural medicine advocates.
8. Manfred Porkert, Chinese Medicine Debased – Essays on Methodology, Dinkelscherben (Germany),
Phainon, 1998, p. 2. In this third point, Manfred Porkert directly targets current Chinese state institu-
tions that are disseminating the teaching of Chinese medicine under the pressure of political motiva-
tions that are better thought out than those under a concern for scientific fidelity to a therapeutic tra-
dition. In the twenty-first century, in addition to the political motivations described by Porkert, there
are also motivations for increasing the scientific outreach of China as well as powerful economic mo-
tives (Évelyne Micollier, art. cit., 2009, pp. 81-82). 
9. Ibid., pp. 13-35; p. 34.
10. Paolo Marandola et al. (ed.), A Comparative Thesaurus of Traditional Chinese and Western Urology, An-
drology and Sexology, Amsterdam, Elsevier, col. “Bridging Hippocrates and Huang Ti,” vol. 1, 2003.
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religion. It is a religion, because it makes the individuals’ integration
in the greater whole understandable. It is secular, because the nu-
minous does not exist in this religion. No god or gods. No demons
or ancestors. (11)
Here we find, on the topic of TCM, the old Western debate between sci-
ence and religion. Torn between a possible status of “science” (defended by
those who not only study it, but also use it as practitioners, such as Volker
Scheid and Manfred Porkert) and a kind of religious doctrine that one must
either believe or doubt (as Paul Unschuld and Kim Taylor both suggest in
their own manner), Chinese medicine struggles to find this epistemological
status, which consequently constitutes the second fundamental issue it
encounters in the process of transmission.
The second issue: Leaving a vague
epistemological status
The question of the relationship between science and religion has been
asked in a much different manner in China than in the West. Knowledge is
not constructed in China in opposition to a religious power. It also did not
form its structure in a discourse involving a pretension of scientific univer-
sality. As a “medical” tradition, the principle motivation by which the Chi-
nese cultivated and transmitted their medical tradition is essentially prac-
tical: only therapeutic effectiveness counted. 
To arrive at concrete therapeutic results, they had to consider human be-
ings who were ill and human beings who were in good health. They uncon-
sciously created a culturally situated anthropology and cosmology. There-
fore Chinese medicine is “Chinese” because it rests on an approach to the
body and mind nourished by a specific civilisation: Chinese culture. In a
world where Western culture has exercised an influence of almost tidal
wave proportions, Chinese medicine offers a way of discovering concretely
how a therapeutic action is possible from the starting point of a perception
of human beings other than what a Western perspective offers. Shigehisa
Kuriyama has demonstrated how perceptions of the body in Greek and
Chinese civilisation are radically different in areas as fundamental as the
history of tactile perception, the relationships between the way of hearing
and seeing, and bleedings:
The true structure and workings of the human body are, we casually
assume, everywhere the same, a universal reality. But when we look
into history, and our sense of reality wavers. (...) Accounts of the
body in diverse medical traditions frequently appear to describe
mutually alien, almost unrelated worlds. (12)
The observation of this difference between the perceptions of the body
conveyed by Taoism and that circulating in the West is the basis of a recent
work by Pierre-Henry de Bruyn, which as an extension of Kristoffer Schip-
per’s ground-breaking book on the Taoist body (13) aims to address the cur-
rent state of this question in Western studies. (14) This work presents Taoism
as a doctrine that is essentially centred on the body. However, to insist ex-
cessively on the Taoist roots (Confucian or Buddhist) of Chinese medicine
would also risk obscuring the epistemological status of the latter rather
than helping to define it. It is therefore better to consider the problem by
going back to what is essential in the act of healing: this is what the Chi-
nese have done over the centuries in transmitting their medical traditions.
Before the nineteenth century, the only “medicine” ( 醫學 – yixue ) that
the Chinese knew was Chinese. Over its long history, Chinese medicine
nonetheless crossed other Asian medical traditions, including, for example,
Indian and Buddhist medicine, as highlighted by Paul Unschuld. (15) On the
other hand, numerous very local Chinese medical traditions or medical
knowledge cultivated in ethnic minority groups exist in China and refer to
medical knowledge based on written (Tibetan, Mongolian, Korean, and
Uyghur medicine) or oral sources. The importation of what is referred to as
“Western medicine” ( 西醫 – xiyi ) upset this intellectual landscape, and
Chinese medical tradition found itself gradually placed in a position of 
relativity in China to the point of soon becoming only a “Chinese” medi-
cine ( zhongyi ). Very soon, certain Chinese medicines tried to propose a
synthesis by attempting to integrate elements of Western medicine into
their traditional medical system: they came to be known as the “school of
integration between Chinese and Western medicines” ( 中西會通牌 –
zhongxi huitong pai ). (16)
Some years later, Mao Zedong renewed these efforts by advocating a
union of Western and Chinese doctors. The debates on the kind of union
envisioned were numerous, and revolved around different slogans. What
order of priority should be considered: “first Chinese medicine and then
Western medicine” ( 先中後西 – xian zhong hou xi ), or the inverse? (17)
Would it be better to think of mutual “integration” ( 結合 – jiehe ), “unifi-
cation” ( 團結 – tuanjie ), “cooperation” ( 合作 – hezuo ), (18) or even “synthe-
sis” ( 綜合 – zonghe )? (19)
However, certain researchers or social actors believe that China will be
able to find its medical legitimacy through its own specificity, rather than
by seeking to join Western medicine with Chinese medicine. They stress
that contemporary Chinese medicine has an urgent need for development
and deep transformation. The Chinese anthropologist Hor Ting thus ex-
plains what many of his compatriots are thinking:
In China, since the transformation of traditional society, Chinese
medicine has been modernized from its traditional aspects. For
most contemporaneous Chinese, as for the author, the moderniza-
tion of Chinese medicine seems quite natural and uncontested. In
fact, this view is formed a priori on three assumptions:
• Chinese medicine has to change from its ancient form to a new form; 
• Chinese medicine has to complete its evolution from its present
primitive level to a higher level;
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11. Paul U. Unschuld, What Is Medicine? Western and Eastern Approaches to Healing, Berkeley/Los Ange-
les, University of California press, 2009, p. 202.
12. Shigehisa Kuriyama, The Expressiveness of the Body – and the Divergence of Greek and Chinese Med-
icine, New York, Zone Books, 1999, p. 8.
13. Kristofer Schipper, The Taoist Body, translated by Karen C. Duval, Berkeley/London, University of Cali-
fornia Press, 1993 (French version: Le corps taoïste, Paris, Fayard, 1982).
14. Pierre-Henry de Bruyn, Le taoïsme – Chemins de découvertes, Paris, CNRS, 2010.
15. Paul Unschuld, Medicine in China: A History of Ideas, University of California Press, Berkeley, 1985.
16. Among other things, Tang Zonghai (1851-1908), Zhang Shouyi (1873-1934), and Zhang Xichun (1860-
1933) were famous supporters of this current.
17. Kim Taylor, op. cit., p. 125.
18. Ibid., p. 137.
19. In the twenty-first century, the use of terms referring to the concept of synthesis is spreading in sym-
posiums, and in official, academic, and popular publications; for example in the context of the First
World Congress of WHO on traditional medicine (chuantong yixue) (WHO Congress on Traditional
Medicine hosted by the Ministry of Health and SATCMC), 7-9 November 2008, on the topic 
“Developing Traditional, Alternative and Complementary Medicines for Today’s Society,” facts and ob-
servations collected by Évelyne Micollier and presented to this Congress. Let us add that Volker Scheid
(2002) formalised this concept.
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• Chinese medicine has to be transformed from an unscientific prac-
tice to a scientific practice. (20)
Then, in a critical approach, Hor Ting himself demonstrates the assump-
tions that he has just defined. According to him, Chinese medicine should
not try to find a new form for itself, because outside of China it is precisely
as “traditional” medicine that it has been adopted by Westerners as a
“medicine of the future.” (21) In addition, since Chinese medicine consti-
tutes “a well-established system of knowledge and skills,” it represents de
facto an “empirico-speculative medicine, developed into its full maturity”
and should not aim for a new metamorphoses in order to be an accom-
plished medical tradition. (22) Finally, by noting that therapeutic efficiency
is what counts in the medical act of healing rather than the scientific ex-
planation provided, (23) Hor Ting goes so far as to reverse perspectives by
declaring, from the point of view of science history, that it is in fact West-
ern medicine that should be considered strange for claiming to base all of
its processes on a “reasonable scientific objectivity” for which it creates its
own unique criteria of truth; thus it should be Western and not Chinese
medicine that represents “an isolated case in medical history.” (24) This rea-
soning shows how the question of the epistemological status of Chinese
medicine can indirectly shake up certain scientific dogmas and can
wrongly lead, by an inverse excess, to caricaturising knowledge called “sci-
entific” and engendering a reductive vision of science, neglecting the fact
that the model of the scientific paradigm consists of a continual reconsid-
eration of previous results through the insertion of new results, and that as
such, the scientific process is only interested in what it can know in the
state of the knowledge of the moment. Furthermore, this paradigm is
based on a theory of knowledge that is “open” in perpetual construction
and thus reconstruction. From this point of view, the epistemological re-
sistance that Chinese medicine encounters in its transmission process is
double: on the one hand, the systematic questioning of its practices and
results required of Chinese medicine by the dominant scientific paradigm
produces internal resistance to a modification of its modes of operation;
on the other hand, compelled to acknowledge its experience through ex-
perimental results that are quantitatively measurable, Chinese medicine is
facing an external challenge of a kind that is totally new in its history.
The third issue: Establishing competent
institutions and efficient public policies
Chinese medicine would not have even the epistemologically vague and
ideologically debated status it has in China and the world today without
the major political support that the authorities of the PRC strategically
chose to give it at the end of the 1950s.
It is indisputable that starting in the 1950s, China established powerful
institutional organisations charged with the national and international dis-
semination of Chinese medicine. (25) In addition, for Kim Taylor, “It is also
noteworthy that only after Hong Kong was returned to China in 1997,
were similar steps taken to institutionalize and standardize the medi-
cine.” (26)
We can at least state that this process intensified after the handover of
Hong Kong. Such strong political support for Chinese medicine by PRC au-
thorities does not, however, justify the reduction of Chinese medicine to a
mere political medical system, or to deduce that the interest of “the West”
was attracted more to the “traditional” aspects of Chinese medicine than
its “scientific merits.” (27) In
fact, if the political charac-
ter of TCM is often decried,
this does not detract from
its scientific or above all
therapeutic merits.
To be able to understand
how the Chinese govern-
ment structures this disci-
pline, or what the political
lines it defines may be, it is
important to know the
principal institutions mo-
bilised to promote and
bring about its institu-
tional dissemination. At
present, the central admin-
istrative organisation in
the development of TCM in
China and in the world is the “State Administration of Traditional Chinese
Medicine of the People’s Republic of China” ( 中華人民共和國國家中醫藥管理
局 – SATCM-PRC ), (28) which has been given two essentials missions. With
the help of members of the vast network that it directs in the various Chi-
nese institutions in China and in the world, this institution must:
1) Formulate strategies, plans, and policies for the development of TCM
and the use of ethnic medicines;
2) Supervise all concrete applications of TCM, both preventive and clini-
cal;
3) Coordinate the integration of TCM and Western medicine;
4) Guide the exploration, summarisation, and improvement of the theo-
retical components of TCM;
5) Direct the protection, exploration, and rational usage at the industrial
scale of Chinese pharmacopoeia;
6) Promote educational activity at all levels in order to ensure the re-
newal of a pool of competencies in TCM;
7) Direct the scientific and technical research likely to improve the credit
granted to TCM;
8) Ensure the protection of the immaterial heritage that constitutes TCM
at the diagnostic and therapeutic level as well as at the literal and cul-
tural level;
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20. Ting Hor, “Modernization of Chinese Medicine: An Anthropologist’s View,” in Ping-Chung Leung et al.,
A comprehensive guide to Chinese medicine, Singapore, World Scientific Publishing Co, ch. 12, pp. 301-
323.
21. Ibid., p. 304.
22. Ibid., p. 307.
23. Ibid., p. 311.
24. Ibid., p. 310.
25. On this question see the detailed study of Wen Xiang, Minguo zhongyi yizheng (The medical policy of
Chinese medicine in the Republic of China), Beijing, Zhongguo Zhongyiyao chubanshe, 2007.
26. Kim Taylor, Chinese Medicine in Early Communist China, 1945 – 1963: A Medicine of Revolution, op.
cit., p. 87.
27. Ibid., p. 109.
28. We choose to use the acronym “SATCM-PRC” rather than “SATCMC,” which is currently used in official
translations (cf. note 19 above), in order to stress the political character of the term: since China is not
only constituted by the PRC, this nuance could be, in certain contexts, as ill-suited as zhongyi as
“TCM.” 
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9) Develop international collaborations for better transmission of TCM in
the world, especially in partnership with Hong Kong, Macao, and Taiwan;
10) And finally – last but not least! – “To perform other tasks given by the
State Council and the Ministry of Health.” (29)
A secretary general and five vice-commissioners preside over this admin-
istration. The careers of these great public servants of Chinese medicine
shed light on the political character of this institution, and the diversity of
their origins testify to its national dimension and the balance between re-
gions. (30) It is also important to stress that none of these officials has train-
ing in biomedicine, but all have post-graduate degrees in Chinese medi-
cine. (31) These two details allow us to stress how much the SATCM-PRC re-
veals a very marked national character and constitutes an atypical form of
organisation compared to Western institutions, where policy decisions on
health issues are typically entrusted to experts trained in biomedicine.
All of these officials serve one common mission: promoting Chinese
medicine in China and in the world according to the wishes and respecting
the instructions of the PRC authorities. Numerous other associations in
China are working in this direction, but always in relationship with this
central authority. Among these we will mention the “Confederation for the
Universalisation of Chinese Herbal Medicine” ( 中藥全球化聯盟 – Zhongyao
quanqiuhua lianmeng ), which was founded in 2003 and aims to bring to-
gether the political authorities of the entire world, universities, research
centres, and the pharmaceutical industry to promote the modernisation of
Chinese medicine, ensure the protection of its cultural capital, improve the
quality of its products, and by creating a platform for exchange, to encour-
age hospital research and bring the tradition of pharmacology and Chinese
medicine into the mainstream of medical studies. Since its foundation, this
confederation has already organized nine academic conferences, the last of
which was held in August 2011 in Shanghai. (32)
The productivity of SATCM-PRC is not limited to China or even to Chi-
nese medicine. It has also contributed to creating awareness at the inter-
national level of the need to establish adequate institutions for the man-
agement of alternative medicine policies that are distinct from those di-
rectly involved in the area of biomedicine. (33) On the other hand, these Chi-
nese organisations lack a similar structure in most other countries. In the
pursuit of international recognition of “Chinese” medicine as belonging to
the “world” heritage of humanity, it would be wise to reflect on the na-
tional or possibly supranational SATCMs (for example a Europe-SATCM),
which would not arise directly from SATCM-PRC, but the creation of which
could be modelled on this institution. South Korea, for example, moved in
this direction by creating a series of institutions in the 1990s for promot-
ing its own medical tradition. (34) The response that the public authorities
of a country or a place can give to the therapeutic needs of practitioners
using Chinese medicine in their medical practices (as well as to the sick
who require them) passes through established political structures adapted
to this specific discipline and healthcare system. The original institutional
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29. The English version: www.satcm.gov.cn/English2010/structure/2010-10-06/150.html (consulted on
23 November 2011).
30. The secretary general, Mr. Wang Guoqiang 王國強, was born in 1955 in Shanghai in a family originally
from Anhui. After working in Inner Mongolia, he entered the CCP in 1973, then studied at the Beijing
College of TCM, where he received his degree in 1978. Beginning in 1983, he worked in the National
Commission responsible for family planning, where he remained active until January 2007, at which
time he became vice-minister of health and the secretary responsible for SATCM-PRC.
31. The five vice-commissioners are: 1) Wu Gang ( 吳剛 ), born in 1953 in Shanxi, graduate of the Beijing
College of TCM in 1976; 2) Yu Wenming ( 于文明 ), born in 1963 in Shandong, graduate of the Shandong
Institute of TCM; 3) Li Daning ( 李大寧 ), born in 1953 in Jilin Province, graduate in CM at the Hei-
longjiang Institute of TCM; 4) Ma Jianzhong ( 馬建中 ), born in Zhengzhou, Henan Province, in 1957,
graduate of the Henan College of TCM in 1976; 5) Wang Zhiyong ( 王志勇 ), born in 1966 in Shanxi,
graduate in 1989 of the Beijing College of TCM.
32. www.zhong-yao.net/new/zy/201109/249110.html (consulted on 23 November 2011).
33. The definition of “traditional medicine” is very large and covers a very diverse range of therapies, prac-
tices, and areas of knowledge according to country and locality. They can be labelled “alternative med-
icines” or “complementary medicines” (CAM – Complementary and Alternative Medicine). The public
policy measures taken by China and its long-term political will to promote traditional medicine en-
counter the concern of states and civil and economic actors on an international scale as well as rec-
ommendations of WHO aiming to integrate traditional medicine into public health systems. Thirty
years ago, at the International Conference on Primary Health Care – Alma-Ata (1978), the Chinese sys-
tem appeared to be a model for other states to imitate, in particular those for whom medical resources
were very limited, with an objective of “Health for All in 2000.” The declaration of Beijing adopted at
the end of the First World Congress of the WHO on traditional medicine, which was held from 7 to 9
November 2008, subscribed to this continuity and called for a more generalised application of broad
parameters of public policy and strategies of WHO for traditional medicine (2002-2005), which were
initiated as of 1987: “Recognising progress achieved by numerous governments to date in integrating
traditional medicines into their systems of national health, we call on those who have not yet done so
to take measures” (paragraph borrowed from Évelyne Micollier, art. cit., 2009, p. 76).
34. See the article by Kang YeonSeok in this issue.
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Chinese experience that constitutes the SATCM-PRC experience, charged
with keeping alive a medical system that is complementary to the domi-
nant system of biomedicine, could justifiably inspire others to carry out
similar initiatives. (35) Determining who in a given country can speak with
authority on Chinese medicine, coordinate training in each discipline, rule
on the competencies required to exercise it, and orient research in this area,
are vital questions for the future of Chinese medicine in the world. They are
neither ideological nor philosophical; they are political and economic.
The fourth issue: Finding the economic
means for development
The fact that Chinese medicine represents a potential source of financial
benefit results endows its organisation with an economic dimension that
further complicates the process of its transmission. Without even talking
about issues of training (which we will address separately below), several
aspects should be stressed in this area: the market for medicinal products,
professional opportunities, reimbursement for healthcare, and research fi-
nancing. We will principally address the situation in China.
The market for medicinal products
The economic issue of the market for Chinese medicine represents the
most obvious financial interest. It influences the current discussions on
Chinese medicine in a decisive manner both in China and abroad. With
some 6,000 manufacturers of medicine in China, capable of producing
more than 1,000 chemical medicines and 8,000 traditional Chinese medi-
cines, a large number of people are involved in marketing these products:
as early as 1999, the Journal of Chinese Medicine counted some 1,000
medicine factories, of which 178 were average to large, with a total pro-
duction valued at over US$23.5 billion  (194.6 billion yuan). (36) This
turnover has increased considerably in the last ten years. In 2007, esti-
mated sales in traditional pharmaceutical products in China increased to
US$5.5 billion out of a total of US$22.6 billion for all medicines com-
bined. (37) The underlying economic dimension of the current discourse of
Chinese authorities promoting the transmission of TCM is omnipresent. A
March 2008 report by the Institute of Chinese Medicine (ICM) of the Chi-
nese University of Hong Kong written at the request of the Hong Kong
government mentions, for example, that:
Chinese medicine naturally enjoys prestige in the field of traditional
medicine [...] One evidence of the revival is rising expenditure on tra-
ditional and alternative medicine in United States and Europe. The
economic potential of Chinese Medicine is therefore international.
[...] If traditional herbal products can be clinically proven efficacious,
the economic potential will increase considerably.
[...] Hong Kong can comfortably develop its hallmark in Chinese
Medicine products and make use of this new endeavour to further
economic growth. (38)
This same report nevertheless mentions that Hong Kong’s Chinese med-
icine industry also confronts numerous difficulties: first, the quality of the
plants is not reliable enough; next, the laboratories responsible for quality
control are deficient; and finally, the number of competent technicians is
insufficient. (39) Further on the report also mentions that the Chinese med-
icine industry lacks both investment and an innovative spirit. (40) This ex-
ample of the questions asked in Hong Kong while considering the trans-
mission of Chinese medicine demonstrates the importance of the eco-
nomic aspects in this process.
The problem of professional opportunities
Apart from purely industrial aspects, we must add the dimensions related
to the problem of professional opportunities for people trained in this
medical system. This problem obviously exists everywhere in the world in
a different manner than in mainland China. In the inquiry on the state of
Chinese medicine in the PRC led by professor Wang Ningsheng ( 王寧生 )
of the Guangzhou University of Chinese Medicine, it is stressed that...
The situation of Chinese medicine (in the PRC), from a therapeutic
point of view, is clearly distinguished by an exceptional situation
and characteristics. Currently in the entire country, there are 3,072
hospitals of Chinese medicine at an urban or higher level, with
332,000 beds and 161 different specialties. In 90 percent of the
hospitals of Western medicines there are departments of Chinese
medicine. 524,000 practitioners have diploma qualifications in Chi-
nese medicine ( 中醫資格證書 – zhongyi zige zhengshu ). 237,000 are
registered as masters in Chinese medicine ( 註冊中醫師 – zhuce
zhongyishi ). The number of registered annual consultations in Chi-
nese medicine is 244 million ( 2.44 億次 – yici ), comprising 18.49
percent of the total number of medical consultations. (41)
The question of professional opportunities for persons trained in Chinese
medicine consequently seems less sensitive in China than in most other
parts of the world. Nonetheless, here, too, a problem remains for two rea-
sons: on the one hand, Chinese medical care is less expensive than that of
Western medicine, bringing in proportionally less money to those who
provide it; on the other hand, the social status of those who practice this
type of medicine suffers from the “non-scientific” reputation of this disci-
pline, and their social recognition tends to weaken. Professor Wang Ning-
sheng thus notes that popular support for Chinese medicine tends to wane
and weaken ( 中醫的民間基礎越來越鬆散薄弱 – Zhongyi de minjian jichu
yuelai yue songsan boruo ).
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35. Regarding the definition of biomedicine, see Anne Guillou and Évelyne Micollier, “Anthropologie et
santé en Asie du sud-est: dynamiques et courants de recherche,” Moussons: Revue de recherche en sci-
ences humaines sur l’Asie du sud-est, no. 15, thematic issue Santé, 2010, pp. 177-193; p. 187, note 3.
36. Figures given by P. C. Leung, “The State of Chinese Medicine in China Today,” op. cit., pp. 205-207.
37. See Catherine Legrand, “Les opportunités d’un marché complexe,” Connexions 45, May-June 2008,
p. 51.
38. Cf. Ping-Chung Leung (principal investigator), Developing Hong Kong into a Chinese Medicine Interna-
tional Platform – A Careful Study, Hong Kong, Institute of Chinese Medicine (CUHK), 2008, p. xx (cited
below under the code DHKCMIP-08). The interest of this document is due to the fact that the infor-
mation it contains is based on a series of inquiries carried out not only in Hong Kong but also in China.
The vice president of the Guangzhou University of Chinese Medicine ( 廣州中醫藥大學 ), Wang Ning-
sheng ( 王寧生 ), led a massive research project covering the province of Guangzhou as well as Nanjing,
Shanghai, Beijing, and even the province of Heilongjiang (p. 17). In 2006, the Committee on Chinese
Medicine and Pharmacy of the Department of Health under Taiwan’s Executive Yuan (Taiwan
xingzhengyuan weishengshu zhongyi weiyuanhui) wrote a similar document entitled Visions of Chi-
nese Medicine in Taiwan.
39. Ibid., p. xxiv.
40. Ibid., p. xxxi.
41. This report directed by Wang Ningsheng is published in Annex 1 of the above-mentioned 2008 report
(DHKCMIP-08) under the title “Neidi zhongyiyao fazhan diaoyan baogao” (Research Report on the De-
velopment of Chinese Medicine in China), p. S6, 3.1.
Special feature
Healthcare coverage policies
The third economic factor likely to influence the development of Chinese
medicine in a major way is medical insurance policies (on consultations,
prescriptions, services, products…). In the PRC, the cost of consultations in
Chinese medicine is covered in a similar manner to that of biomedicine. In
Singapore, Chinese medicine is covered by medical insurance, even in pri-
vate clinics, while in Taiwan the reimbursement rate varies among different
insurance plans.
The well-known arguments in favour of allowing patients the choice of
Chinese medicine include a lesser probability of secondary effects and a
lower cost, except for patients who seek the highest-quality products and
services. (42) This means lower cost for health insurers. Comparing costs
concretely, it suffices to observe the prescription counters of a typical hos-
pital in a major Chinese city that provide both types of medicines; in fact,
all patients with a prescription go to these counters. Traditional and bio-
medical products are often, but not always, supplied separately in two hos-
pital pharmacies located side by side. The personnel generally consist of
pharmacists or specialised assistants. For a common benign pathology, less
than 10 yuan is needed to procure ordinary traditional pharmacopeia
products, while a package of Paracetamol, for example, costs around 20
yuan, and a package of antibiotics costs double that. (43) Let us clarify that
the hospital sector is the main supplier of medicine in China, covering
around 80 percent of the total market. In the twenty-first century, phar-
macies functioning outside the hospital system have developed a lucrative
market of “OTC” (over the counter) products (44) to increase their share of
the domestic market; they thus sell a certain number of traditional medi-
cines carrying the OTC label.
That being said, it is nonetheless necessary, as far as China is con-
cerned, (45) to limit the impact that healthcare coverage has on the use of
Chinese medicine, given that only a small minority (20 percent) of the
Chinese population was covered by health insurance in the early
2000s, (46) and that sources estimated that 15 to 20 percent of the popu-
lation receives 60 to 80 percent of all public medical resources. The priv-
ileged social categories are mainly employees of government or state en-
terprises. Fifty percent of the urban population and 80 percent of the rural
population have no medical coverage; 50 percent of the inhabitants of
rural zones do not have access to healthcare due to its cost (WHO, coun-
try file, 2000). Deteriorating infrastructure, lack of personnel, and evi-
dence of an increased prevalence of some pathologies have been ac-
knowledged in most rural zones. (47) Over the past two decades, the basic
Chinese healthcare that WHO held up as a model for developing coun-
tries has completely disappeared in favour of a commercialised and de
facto privatised system based on forcing public health structures to fund
themselves. The healthcare reform officially launched in 2009 (48) has as its
main objective reduction of inequalities in healthcare and thus
poverty. (49) Made public in 2008 and 2009, the guidelines envision the
generalisation of a health insurance system with basic coverage for 90
percent of the population in 2011, improved access to healthcare centred
on hospital reform, and finally, consistent financing and medical supplies
to hospitals in order to curb the abuses of excessive commercialisation.
This reform will thus have considerable influence a priori on the develop-
ment of Chinese medicine, because it will facilitate, in principle, access to
medical care for a majority of the population and therefore access to
treatment with Chinese medicine.
Funding research
The last decisive economic factor is that of financing research in Chinese
medicine. There are two dangers here, one extrinsic and the other intrinsic
to the discipline. On the one hand, in promoting research, for example aim-
ing at the identification of “active elements” in Chinese pharmacopeia, the
pressure of the large pharmaceutical groups (foreign or Chinese) may pro-
gressively cause work in this area to develop too unilaterally in a direction
that is foreign and even destructive to dimensions that are fundamental to
the specific cultural heritage that constitutes Chinese medicine. (50) On the
other hand, Chinese medicine, which builds on the historic accumulation
of numerous therapeutic experiences, still struggles to develop the specific
processes of experimentation and testing that are universally acknowl-
edged by the scientific community.
In China, research in Chinese medicine is principally financed within the
framework of the R&D programs of Chinese pharmaceutical groups. Cer-
tain groups exclusively produce and market Chinese medical products;
other businesses are not specialised and also finance research into bio-
medicine and integrated medicine. The protocols of biomedical research
can also integrate elements that come from Chinese medicine, while con-
versely those of Chinese medicine can do so with elements of biomedicine.
State organs such as the Ministry of Heath, the Ministry of Science and
Technology, and the Ministry of Culture and Heritage also contribute to
developing research in Chinese medicine. The government substantially in-
creased its financial support in the twenty-first century. In the framework
of research in industrial, university, or hospital environments, a single sci-
entific methodology tends to be applied.
At the heart of complex economic issues, research and development in
Chinese medicine has entered the framework of the world health market
by virtue of its potential for putting products  of pharmacotherapy ( 中醫
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42. In this case, the cost of treatment can greatly exceed that of generic biomedical products manufac-
tured by Chinese businesses.
43. Observations made by Évelyne Micollier in Beijing and Guangzhou in 2007-2008.
44. The international term applied to products that can be sold without prescription and are designed to
treat benign pathologies. Local and/or national regulations apply to the attribution of this label.
45. The paragraph that follows is adapted from the article by Évelyne Micollier, “Why is a reform of the
health system urgent?” in Fabrice Duléry (ed.), Aujourd’hui la Chine, CRDP academy of Montpellier and
CNDP (Centre National de Documentation Pédagogique), Montpellier, 2011, pp. 88-90.
46. The health care system prior to the Reform Era (1979- ) was necessarily very rudimentary but had the
merit of being more egalitarian, with nearly 90 percent of the population benefiting from care that was
essentially free through the support of national, provincial, or local healthcare systems. According to
an official report of the World Bank (World Bank, 1997, China 2020: Financing Health Care, Washington
D.C., World Bank, p. 1), in 1975, the main portion of healthcare costs was assumed by the rural coop-
erative system, the government, and SOEs and benefited nearly 90 percent of the population (almost
all the urbanites and 85 percent of the rural population).
47. See Marilyn Beach, “China’s rural health care gradually worsens,” The Lancet, 2001, vol. 358, p. 567.
48. Chen Zhu, “The Launch of the health-care reform plan in China,” The Lancet, 2009, vol. 373, pp. 1322-
1324.
49. It has already been the object of numerous publications because there were great expectations
among national and international actors in development (see OCDE 2006 report). Among these pub-
lications, see the remarkable collection of articles on health in general and the reform in particular
published on-line in the prestigious journal The Lancet, 2008 and 2009, www.thelancet.com; WHO
bulletins including Hu Shanlian “Universal Coverage and health financing from China’s perspective,”
Bulletin of the World Health Organization, 2008, vol. 86, no. 11, p. 819; J. Parry, Cui Weiyuan, “Making
health care affordable in China,” Bulletin of the World Health Organization, 2008, vol. 86, no.  11,
pp. 821-823; on the multiple challenges posed by the reform and the internal debate that it brings
about, cf. Lu Xiaoqing, Charles W. Freeman, China’s Capacity to Manage Infectious Diseases: Global
Implications, Center for Strategic and International Studies, March 2009, chap. 5 and 6.
50. For example: the fact that the categories used in diagnosis are the same as those used to classify
plants; those of plants are almost always part of a formula (which is itself the result of long experi-
ence), and the therapeutic attribute of the plant is sometimes related to the rhythm of the seasons.
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藥 – zhongyiyao ) and traditional pharmacology ( 中醫藥學 – zhongyi
yaoxue ) on the market. These products constitute a welcome market
niche for the Chinese pharmaceutical industry, comprised largely of
government-run firms. Following the constraints placed on China with
its entry into the WHO (2001), these companies had to quickly change
strategies because they could no longer systematically manufacture
generic versions of patented biomedical products from developed coun-
tries, which at that time constituted almost their total production. Ne-
gotiations for the development of international research in Chinese
medicine confirmed the strategy of Chinese industry and authorities
obtaining MA (Marketing Authority) in developed countries by register-
ing pharmacopoeia compounds. The objective was to be able to enter
the market by registering in the category of medicine rather than in the
category of food supplements. However, the legal framework and stan-
dards of scientific evidence are much more stringent for medicines;
these standards prescribe implementation of the EBM model (Evidence-
Based Medicine) and the carrying out of conclusive clinical trials. A
“flexible” MA is envisaged in the regulatory framework of the European
Medicines Agency for non-conventional medicines, which covers: (1)
medicines with well established medical uses, i.e., for which biblio-
graphic or experimental evidence of safety and efficacy have been pro-
vided; and (2) “traditional” medicines for which a “long” tradition of use
(a minimum of 30 years, 15 of which are in the European community)
is acknowledged (Directive 200424/EC). Numerous scientific research
projects aimed at testing Chinese medical products have been launched
in the twenty-first century: for example, the Herbalome project, ambi-
tious and long-term (15 years), was presented in the review Science.
They are based on methods such as high-level screening, toxicity tests
and clinical trials: the objective is to identify active and toxic substances
in TCM compounds. (51) Another example involves a call for projects by
the French ANR (French National Research Agency), launched in 2008 in
the framework of the program of biotechnologies for health, which ex-
plicitly mentioned Chinese medicine. The call is significant in terms of
an increasing number of scientific policies encouraging the develop-
ment of scientific research within the framework of a French-Chinese
partnership of public research. (52) It must be emphasised, however, that
despite a bilateral political effort, no project was financed in the frame-
work of this call at the end of the day. (53)
The fifth issue: Innovation in specific
education
The fifth type of major issues that transmission of the heritage of
Chinese medicine faces concerns the specific teaching method of this
discipline. Jumping suddenly during the 1950s from an individualised
mode of transmission, most often intra-familial, to a more institu-
tional and university structure, the teaching of Chinese medicine has
not yet recovered, even in China, from this fundamental change. Three
observations attest to this: the quasi-cult of the “laozhongyi” ( 老中醫
– venerable doctors ) (54) organised at a local and even national level;
the survival of the official validation of competencies acquired by
study with a master in Chinese medicine outside of any parallel insti-
tutional course of studies; and the request by certain teachers of Chi-
nese medicine in China for the return to a more classical teaching
method. (55)
In China, traditional medicine has long been considered to involve a great
deal of knowledge twice over, on the one hand because practical mastery
could only be acquired through long personal experience (taking pulses, di-
agnosis, discerned modifications of pharmacopeia formulas according to the
needs of each particular patient, etc.), and on the other hand, because its
theoretical knowledge required a vast literary culture of texts written in clas-
sical Chinese. (56) The challenge of finding teachers excelling in both areas has
arisen in China today with force. Recurring demands for a return to more
classical teaching are currently heard in the world of classical medicine. Sev-
eral proposals by Professor Liu Lihong ( 劉力紅 ) illustrate this point. (57)
In his training, Liu Lihong embodies a mixture of two pedagogic tradi-
tions. Trained during nine successive years at various modern Chinese uni-
versities (1978-1983: student at the Guangxi faculty of MC; 1983-1989:
researcher in the department of heat damage disorder [ 溫病研究室 – wen-
bing yanjiu shi ], the last three years of which he spent in Chengdu; 1989-
1992: doctorate at the Nanjing faculty of MC under the direction of pro-
fessor Chen Yiren [ 陳亦人 1924-2004 ]), he then returned to Guangxi to
teach fundamental theories, and was subsequently invited to Tsinghua
University from 2002 to 2003. During this training he also had the oppor-
tunity to follow more traditional training – as is done in China by many
disciples who accompany masters to become initiated into medical prac-
tices through daily contact. (58)
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51. Science review, “TCM under the microscope: Researchers hope the project will lead to better quality
control,” 12 February 2008.
52. www.agence-nationale-recherche.fr/AAPProjetsOuverts?NodId=17&lngAAPId=227 (consulted on 23
November 2011), PDF program, p. 83, by Évelyne Micollier.
53. This long paragraph borrows from Évelyne Micollier (art. cit., 2009, p. 82; art. cit., 2011, pp. 87-88).
54. The character “lao” has a primary meaning of “old,” but here it should be translated as “venerable” in-
stead.
55. For the cult of laozhongyi, also see in this issue the description by Éric Marié and Frédéric Obringer of
recent attempts to revalorise master-teacher instruction ( 師徒傳承 – Shitu chuancheng ).
56. The difficulty of finding and training at least some specialists able to assimilate knowledge in this tra-
dition that is not only practical (faculties of medicine) or literary (faculties of sinology), but which
unites these two aspects, is of course much greater in the West than in China. France has a long tra-
dition of innovation in this area. As early as 1813, Dr. Abel Rémusat (1788-1832) presented a disser-
tation on Chinese medicine (Dissertatio de glossosemeiotice sive de signis morborum quae e lingua
sumuntur, praesertim apud sinenses). The next year, he was appointed to the chair of Chinese and Tar-
tar-Manchu language and literature at the Collège de France. Later, in the 1970s, Taoist studies were
inaugurated in Paris around the works of Kristofer Schipper. Today, 200 years after the thesis of Abel
Rémusat, why not envisage the creation of a French or European chair of Chinese medicine aimed at
promoting in France and in Europe the protection, and thus the transmission, of what has now become
a cultural heritage of humanity?
57. Born in 1958, Liu Lihong in 1992 became the first holder of a doctorate in TCM from the province of
Guangxi. He has been teaching at the University of TCM of this autonomous region since 1997, spe-
cialising in the use of classical formulas for the treatment of chronic illnesses. Known as a great spe-
cialist of Shang Han Lun (Treatise on Febrile Diseases), a classic of Chinese medicine written in the sec-
ond century by Zhang Zhongjing ( 張仲景 150-219 ), Liu Lihong became famous through the publica-
tion of two works: Kaiqi zhongyi zhi men (Opening the Doors of Chinese Medicine, 1998) and above
all Sikao zhongyi (Reflecting on Chinese Medicine, 2004) which is presented as a knowledge commen-
tary on Shang Han Lun. Reading the latter book, one of the most famous contemporary Chinese doc-
tors, Professor Deng Tietao ( 鄧鐵濤 born in 1916 ), said: “I no longer walk my path alone; there is some-
one behind me who wants to continue the tradition of MCT… ( 吾道不孤,後繼有人矣 – wu dao bu gu,
hou ji you ren yi ). The conversation between Liu Lihong and Wang Qingyu on the nature of the nec-
essary transmission in Chinese medicine (www.classicalchinesemedicine.org/2011/01/3050), and Liu
Lihong’s deep conviction on the primordial role of emotions ( 感動 – gandong ) in this process
(www.classicalchinesemedicine.org/2011/02/liu-lihong-reflections-on-gandong-real-transmission-of-
knowledge-requires-that-our-hearts-are-moved), demonstrate how central the question of the mode
of transferring knowledge is to his reflections on the future of TCM.
58. Thus Liu Lihong spent a period of seven years with Li Yangbo ( 李陽波, 1947-1991 ), and recognises that
he owes the essential part of his first work to him. For two of those years he lived with Li Yangbo as
well as other masters such as Wang Qinyu ( 王慶餘 1932-2002 ) and Zeng Basheng ( 鄫雝生, www.hun-
yuan.org/main_html. php?page=qanda&subpage=24 ), who taught him Taoism, and certain doctors
such as, in 2004, Dr. Li Ke ( 李可 ), an elderly doctor working in Shanxi sometimes called Li Lao ( –
old Li ), and in 2006, Lu Chonghan ( ) in Chengdu, a grand master of the third generation of the
school of medical tradition called huoshen pai ( 火神派 – current of spiritual fire ) founded by Zheng
Qin’an ( 鄭欽安 1804-1901 ) at the end of the nineteenth century.
Special feature
In certain passages of his book Reflecting on Chinese Medicine, Liu Li-
hong paints a relatively sombre situation for Chinese medicine in China: (59)
Whether in academies of Chinese medicine or in departments of
Chinese medicine of Western academies of Oriental medicine, Chi-
nese medicine has become almost a mere ornament. Those who
study Chinese medicine don’t have confidence in it: as soon as they
encounter a bit of difficulty, they either hastily administer Western
medication or add to the standard Western remedies a bit of Chi-
nese medicine to do a bit good […] Seeing Chinese medicine fall so
low can only lead to gloom. (60)
He points out:
These last ten years, a question often raised in the world of Chinese med-
icine is why the theory of Chinese medicine has stopped at clinical prob-
lems. In all scientific disciplines, it is theory that walks in the forefront
while practice slowly follows behind. (61)
But contrary to this idea of a Chinese medicine devoid of a specific the-
oretical foundation, Liu Lihong sets out his personal position as follows:
The way I see it is quite the opposite: theory [of Chinese medicine]
has not experienced regression ( 沒有落後 – meiyou luohou ), but
has even made enormous progress ( 大大的超前 – dada de chao-
qian ) in many areas.
For him, an important problem is the didactic one:
Currently in Chinese medicine there is a strange and even frighten-
ing phenomenon that consists of a progressive weakening of the
teaching of the classics of Chinese medicine. Most contemporary
academies of Chinese medicine have already transformed [the
study] of the classics into an optional (elective) course – those of
Chengdu or Nanjing, honourable institutions that in the past gave
such weight to this material, have not been the exception. But does
this type of transformation truly constitute progress? I have serious
doubts. (62)
According to Liu Lihong, the study of the classics is an indispensable el-
ement in learning Chinese medicine:
The classics are for life, [for the practitioner of Chinese medicine] a
compulsory course: if you really want to study Chinese medicine,
then working on the classics in depth is the type of project that you
must do of necessity. (63)
This study is doubly difficult. From a literary point of view, the study of
the classics of Chinese medicine requires a high philological intelligence al-
lowing the student to progressively grasp the multiple meanings of a text
and then penetrate the meaning of words ( 字義 – ziyi ) and sentences ( 句
義 – juyi ), as well as the overall meaning ( 總義 – zongyi ) of the text. Next,
this process requires the inner cultivation of a receptive spirit toward the
subtext. Thus Liu Lihong states:
Another problem to which we must pay attention in order to study
the classics [of Chinese medicine] well is to fulfil a fundamental
condition, or to put it another way, to acquire an essential quality:
knowing how to undertake this study in a state of a faithfully re-
spectful receptivity ( 信受舉行 – xinshou juxing ). In our modern
times, many study the classics [of Chinese medicine] by approach-
ing them with a critical eye, considering the classics unscientific and
therefore beneath the intelligence of the students; but then, what
classics would they study? If you launch yourself into study of the
classics with antipathy and considering them outmoded, how will
you be able to enter into it? This is why the attitude brought to
studying the classics is so important; you must believe them com-
pletely, accept them, and then reflect on how to act in conformance
with their spirit. (64)
The Liu Lihong’s comments cited obviously cannot summarise the
thoughts deeply cultivated by a detailed and living study of Shang Han
Lun, but they do demonstrate the vigor with which a return to a teaching
of TCM based on the classics can be defended today in China. The impor-
tance given to a study of the classics in the learning of Chinese medicine
is explained by the fact that the medical practice inherits a long human ex-
perience of individuals who have fought for centuries to maintain health,
defeat illness, and hold off death. By basing itself mainly on the scientific
and experimental objectivity of “contemporary” science, according to the
scientific paradigm it prescribes, biomedicine tends to consider these ther-
apeutic experiences of the past as relatively outmoded vis-à-vis the
strength of experimental evidence. (65)
This is what constitutes its specific strength, but what can sometimes be
felt as oppressive by practitioners of Chinese medicine:
Obviously the methods for arriving at a diagnosis in Chinese medi-
cine and in Western medicine are profoundly different. The Western
doctor has a large number of modernised methods to help him, and
these methods themselves are always progressing. What is the state
of this regarding Chinese medicine? It has nothing similar: in all
things it can only base itself on itself. That is why studying Chinese
medicine is more difficult than studying Western medicine. If you
study Western medicine, all the techniques of the entire world
come to your aid: modern physics helps you; modern chemistry
supports you; modern biology helps you some more. But if you
study Chinese medicine, nobody helps you; on the contrary, you
seem determined to complicate your life. That is why if somebody
wants to succeed in studying Chinese medicine, especially in the
context of the current modernisation, it is really no easy matter.
Everyone must think long and hard about this problem and allow an
unshakable confidence to take root [in the value of Chinese medi-
cine]. (66)
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(2009), p. 1.
60. Ibid., p. 14.
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65. It should be noted, however, that the clinical experience given by case studies is recognised as impor-
tant in all medical disciplines.
66. Liu Lihong, op. cit., p. 127.
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Conclusion
The analysis of the principal issues that polarise discussions on Chinese
medicine and that influence its process of institutional transmission does
not allow us to imagine the future and even survival of this medical tradi-
tion without a certain trepidation. Professor Xie Peishan ( 謝培山 – 1934- )
illustrated this point by saying: “In reality, the future of Chinese medicine
today hangs by a thread” ( 中醫藥的前途實際上是處在命懸一線的關口 –
zhongyiyao de qiantu shijishang shi chuzai mingxuanyixian de
guankou ). (67)
The reflections above indicate several focal points that could allow con-
sideration of the future with a greater sense of ease:
1. Be aware of the current ideological polarisation of the debates, in
China as well as in the West, between partisans and opponents of Chi-
nese medicine;
2. Reconfirm as central the therapeutic perspective of the medical act
vis-à-vis the theoretical model of approach to the body on which its
efficiency is based;
3. Build adequate political structures on a national as well as suprana-
tional level to ensure global management of the application of this
medical tradition;
4. Take greater account of the multiple economic factors likely to influ-
ence the development and reception of this tradition;
5. Encourage pedagogic initiatives (respectful at the same of the history
of didactics specific to the discipline and the demands of scientific
training at an international level) that promote superior instruction in
this medical tradition. (68)
On the other hand, we should not underestimate the fact that advan-
tages favouring the institutional transmission of certain Chinese medicine
on a global level can be identified: the size and influence of Chinese dias-
poras throughout the world, the key positions held by Chinese profession-
als at WHO, Chinese medicine’s relatively lower cost compared to biomed-
icine for transmission to developing countries, and finally, the increased in-
ternational mobility of traditional doctors and a middle class that is
equally mobile and considers Chinese medicine a heritage to be preserved,
valued, and promoted. This mobility has certainly been facilitated by
China’s economic development. As a complement to the highlighted issues
in this article, all these factors help explain why Chinese medicine is al-
ready a world medicine. Consequently, the prospects for future research
aimed at identifying the forms that are developing in the context and
transformation of this very living knowledge are numerous and promising.
z Translated by Maxi Schwarz-Bastami
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68. An official report given to the Hong Kong authorities in 2001 stated the urgency of teaching this tra-
dition in a way that will allow it to become international, which implies defined courses with exams
of which the validation is duly recognised (DHKCMIP-08, p. 22). One example in this direction is the
three university degrees in Chinese medicine that have been created these last few years at the faculty
of medicine of Montpellier University, in the framework of a political partnership with the city of
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